Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Depreciation and Depletion (2020 - 2025)

Biofrontera (BFRI) has 6 years of Depreciation and Depletion data on record, last reported at $17000.0 in Q3 2025.

  • For Q3 2025, Depreciation and Depletion fell 15.0% year-over-year to $17000.0; the TTM value through Sep 2025 reached $94000.0, up 13.25%, while the annual FY2024 figure was $92000.0, 6.98% up from the prior year.
  • Depreciation and Depletion reached $17000.0 in Q3 2025 per BFRI's latest filing, down from $22000.0 in the prior quarter.
  • Across five years, Depreciation and Depletion topped out at $33000.0 in Q1 2021 and bottomed at $5000.0 in Q4 2021.
  • Average Depreciation and Depletion over 5 years is $23315.8, with a median of $22000.0 recorded in 2023.
  • Peak YoY movement for Depreciation and Depletion: soared 320.0% in 2022, then fell 21.43% in 2023.
  • A 5-year view of Depreciation and Depletion shows it stood at $5000.0 in 2021, then skyrocketed by 320.0% to $21000.0 in 2022, then changed by 0.0% to $21000.0 in 2023, then surged by 42.86% to $30000.0 in 2024, then plummeted by 43.33% to $17000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Depreciation and Depletion were $17000.0 in Q3 2025, $22000.0 in Q2 2025, and $25000.0 in Q1 2025.